These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11084179)

  • 1. Depot medroxyprogesterone acetate and basal serum prolactin levels in lactating women.
    Ratchanon S; Taneepanichskul S
    Obstet Gynecol; 2000 Dec; 96(6):926-8. PubMed ID: 11084179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders.
    Keder LM; Rulin MC; Gruss J
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):583-5. PubMed ID: 9757955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density in women using depot medroxyprogesterone acetate for contraception.
    Scholes D; Lacroix AZ; Ott SM; Ichikawa LE; Barlow WE
    Obstet Gynecol; 1999 Feb; 93(2):233-8. PubMed ID: 9932562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
    Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
    J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation rates and complications of intrauterine contraception in women diagnosed with bipolar disorder.
    Berenson AB; Asem H; Tan A; Wilkinson GS
    Obstet Gynecol; 2011 Dec; 118(6):1331-1336. PubMed ID: 22105263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot medroxyprogesterone acetate contraceptive injections and skeletal health.
    Renner RM; Edelman AB; Kaunitz AM
    Womens Health (Lond); 2010 May; 6(3):339-42. PubMed ID: 20426597
    [No Abstract]   [Full Text] [Related]  

  • 9. New aspects of injectable contraception.
    Phillips OP
    Int J Fertil Womens Med; 2001; 46(1):31-6. PubMed ID: 11294618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting contraceptive options.
    Kaunitz AM
    Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q; Jiang H; Fu W
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
    Vercellini P; De Giorgi O; Oldani S; Cortesi I; Panazza S; Crosignani PG
    Am J Obstet Gynecol; 1996 Aug; 175(2):396-401. PubMed ID: 8765259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo.
    Abasiattai AM; Udoma EJ; Ukeme E
    Ann Afr Med; 2010; 9(2):81-5. PubMed ID: 20587929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum contraceptive use among adolescent mothers.
    Templeman CL; Cook V; Goldsmith LJ; Powell J; Hertweck SP
    Obstet Gynecol; 2000 May; 95(5):770-6. PubMed ID: 10775745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RETIRED: Canadian contraception consensus--update on Depot Medroxyprogesterone Acetate (dmpa).
    Black A; ;
    J Obstet Gynaecol Can; 2006 Apr; 28(4):305-308. PubMed ID: 16776909
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
    Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up.
    dos Santos Pde N; Modesto WO; Dal'Ava N; Bahamondes MV; Pavin EJ; Fernandes A
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):432-8. PubMed ID: 25047227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary tract infection in the users of depot-medroxyprogesterone acetate.
    Ziaei S; Ninavaei M; Faghihzadeh S
    Acta Obstet Gynecol Scand; 2004 Oct; 83(10):909-11. PubMed ID: 15453884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylaxis from depot medroxyprogesterone acetate in an adolescent girl.
    Lestishock L; Pariseau C; Rooholamini S; Ammerman S
    Obstet Gynecol; 2011 Aug; 118(2 Pt 2):443-445. PubMed ID: 21768848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.